Reproducibility of prefrontal γ-aminobutyric acid measurements with J-edited spectroscopy

NMR in Biomedicine

Volumn 24, Issue 9, 2011, Pages 1089-1098

  Geramita, Matthew ^a   van der Veen, Jan Willem ^a   Barnett, Alan S ^a   Savostyanova, Antonina A ^a   Shen, Jun ^a   Weinberger, Daniel R ^a   Marenco, Stefano ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

3T; Anterior cingulate cortex; Creatine; Glutamate+glutamine (Glx); Gray matter; MRS; N acetylaspartic acid; White matter

Indexed keywords

3T; ANTERIOR CINGULATE CORTICES; CREATINE; GLUTAMATE+GLUTAMINE (GLX); GRAY MATTER; MRS; N-ACETYLASPARTIC ACID; WHITE MATTER;

BIOMOLECULES; BRAIN; DATA HANDLING; EXTRAPOLATION; MACROMOLECULES; METABOLISM; METABOLITES; SPECTROSCOPIC ANALYSIS;

AMINO ACIDS;

4 AMINOBUTYRIC ACID; CREATINE; GLUTAMIC ACID; GLUTAMINE; N ACETYLASPARTIC ACID;

ADULT; ANTERIOR CINGULATE; ARTICLE; CEREBROSPINAL FLUID; CORRELATION COEFFICIENT; FEMALE; GRAY MATTER; HUMAN; HUMAN EXPERIMENT; MACROMOLECULE; MALE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PREFRONTAL CORTEX; PRIORITY JOURNAL; REPRODUCIBILITY; WHITE MATTER;

ADULT; CONFIDENCE INTERVALS; FEMALE; GAMMA-AMINOBUTYRIC ACID; GYRUS CINGULI; HUMANS; MACROMOLECULAR SUBSTANCES; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PREFRONTAL CORTEX; PROTONS; REPRODUCIBILITY OF RESULTS; YOUNG ADULT;

EID: 80051560326     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1662     Document Type: Article

References (49)

1. Wong CG, Bottiglieri T, Snead OC 3rd. GABA, gamma-hydroxybutyric acid, and neurological disease. Ann. Neurol. 2003; 54 (Suppl 6): S3-S12.
2. Shen J, Rothman DL, Brown P. In vivo GABA editing using a novel doubly selective multiple quantum filter. Magn. Reson. Med. 2002; 47(3): 447-454.
3. Choi IY, Lee SP, Merkle H, Shen J. Single-shot two-echo technique for simultaneous measurement of GABA and creatine in the human brain in vivo. Magn. Reson. Med. 2004; 51(6): 1115-1121.
4. Du F, Chu WJ, Yang B, Den Hollander JA, Ng TC. In vivo GABA detection with improved selectivity and sensitivity by localized double quantum filter technique at 4.1T. Magn. Reson. Imaging, 2004; 22(1): 103-108.
5. Ke Y, Cohen BM, Bang JY, Yang M, Renshaw PF. Assessment of GABA concentration in human brain using two-dimensional proton magnetic resonance spectroscopy. Psychiatry Res. 2000; 100(3): 169-178.
6. Thomas MA, Yue K, Binesh N, Davanzo P, Kumar A, Siegel B, Frye M, Curran J, Lufkin R, Martin P, Guze B. Localized two-dimensional shift correlated MR spectroscopy of human brain. Magn. Reson. Med. 2001; 46(1): 58-67.
7. Lymer K, Haga K, Marshall I, Sailasuta N, Wardlaw J. Reproducibility of GABA measurements using 2D J-resolved magnetic resonance spectroscopy. Magn. Reson. Imaging, 2007; 25(5): 634-640.
8. 1H NMR measurements of gamma-aminobutyric acid in human brain in vivo. Proc. Natl. Acad. Sci. USA, 1993; 90(12): 5662-5666.
9. Sailasuta N, LeRoux P, Hurd R, Wang P, Sachs N, Ketter T. Detection of cerebral gamma-aminobutyric acid (GABA) in bipolar disorder patients and healthy volunteers at 3T. Proceedings of the 9th Annual Meeting ISMRM, Glasgow, UK, 2001; 1011.
10. Hasler G, Neumeister A, van der Veen JW, Tumonis T, Bain EE, Shen J, Drevets WC, Charney DS. Normal prefrontal gamma-aminobutyric acid levels in remitted depressed subjects determined by proton magnetic resonance spectroscopy. Biol. Psychiatry, 2005; 58(12): 969-973.
11. de Graaf R. In Vivo NMR Spectroscopy, Principles and Techniques. John Wiley & Sons Ltd.: Chichester, West Sussex, 2007.
12. Bogner W, Gruber S, Doelken M, Stadlbauer A, Ganslandt O, Boettcher U, Trattnig S, Doerfler A, Stefan H, Hammen T. In vivo quantification of intracerebral GABA by single-voxel (1)H-MRS - how reproducible are the results? Eur. J. Radiol. 2010; 73(3): 526-531.
13. Evans CJ, McGonigle DJ, Edden RA. Diurnal stability of gamma-aminobutyric acid concentration in visual and sensorimotor cortex. J. Magn. Reson. Imaging, 2010; 31(1): 204-209.
14. Harada M, Kubo H, Nose A, Nishitani H, Matsuda T. Measurement of variation in the human cerebral GABA level by in vivo MEGA-editing proton MR spectroscopy using a clinical 3T instrument and its dependence on brain region and the female menstrual cycle. Hum. Brain Mapp. 2010; in press.
15. Mescher M, Merkle H, Kirsch J, Garwood M, Gruetter R. Simultaneous in vivo spectral editing and water suppression. NMR Biomed. 1998; 11(6): 266-272.
16. Egan MF, Goldberg TE, Gscheidle T, Weirich M, Bigelow LB, Weinberger DR. Relative risk of attention deficits in siblings of patients with schizophrenia. Am. J. Psychiatry, 2000; 157(8): 1309-1316.
17. Kegeles LS, Mao X, Gonsalez R, Shungu DC. Evaluation of anatomic variation in macromolecule contribution to the GABA signal using metabolite nulling and the J-editing technique at 3.0T. Proceedings of the 15th Annual Meeting ISMRM, Berlin, Germany, 2007; 1391.
18. van der Veen JW, Shen J. Residual water as a navigator in GABA editing spectroscopy. Proceedings of the 14th Annual Meeting ISMRM, Seattle, WA, USA, 2006; 490.
19. Vanhamme L, Fierro RD, Van Huffel S, de Beer R. Fast removal of residual water in proton spectra. J. Magn. Reson. 1998; 132(2): 197-203.
20. Ashburner J, Friston K. Multimodal image coregistration and partitioning - a unified framework. Neuroimage, 1997; 6(3): 209-217.
21. Tofts P. Quantitative MRI of the Brain: Measuring Changes Caused by Disease. John Wiley & Sons Ltd.: Chichester, West Sussex, 2003.
22. Aubert-Broche B, Evans AC, Collins L. A new improved version of the realistic digital brain phantom. Neuroimage, 2006; 32(1): 138-145.
23. Lin C, Bernstein M, Huston J, Fain S. Measurements of T1 relaxation times at 3.0T: implications for clinical MRA. Proceedings of the 9th Annual Meeting ISMRM, Glasgow, UK, 2001; 1391.
24. Piechnik SK, Evans J, Bary LH, Wise RG, Jezzard P. Functional changes in CSF volume estimated using measurement of water T2 relaxation. Magn. Reson. Med. 2009; 61(3): 579-586.
25. Stanisz GJ, Odrobina EE, Pun J, Escaravage M, Graham SJ, Bronskill MJ, Henkelman RM. T1, T2 relaxation and magnetization transfer in tissue at 3T. Magn. Reson. Med. 2005; 54(3): 507-512.
26. Sumner P, Edden RA, Bompas A, Evans CJ, Singh KD. More GABA, less distraction: a neurochemical predictor of motor decision speed. Nat. Neurosci. 2010; 13(7): 825-827.
27. Kreis R, Ernst T, Ross BD. Absolute quantitation of water and metabolites in the human brain. II Metabolite concentrations. J. Magn. Reson. Ser. B, 1993; 102: 9-19.
28. Ernst T, Kreis R, Ross BD. Absolute quantification of water and metabolites in the human brain. I. Compartments and water. J. Magn. Reson. Ser. B, 1993; 102: 1-8.
29. Bland JM, Altman DG. Measurement error. Br. Med. J. 1996; 312(7047): 1654.
30. Bartko JJ, Carpenter WT Jr. On the methods and theory of reliability. J. Nerv. Ment. Dis. 1976; 163(5): 307-317.
31. Faul F, Erdfelder E, Lang AG, Buchner A. G Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav. Res. Methods, 2007; 39(2): 175-191.
32. Hasler G, van der Veen JW, Tumonis T, Meyers N, Shen J, Drevets WC. Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. Arch. Gen. Psychiatry, 2007; 64(2): 193-200.
33. Hasler G, van der Veen JW, Geraci M, Shen J, Pine D, Drevets WC. Prefrontal cortical gamma-aminobutyric acid levels in panic disorder determined by proton magnetic resonance spectroscopy. Biol. Psychiatry, 2009; 65(3): 273-275.
34. Waddell KW, Zanjanipour P, Pradhan S, Xu L, Welch EB, Joers JM, Martin PR, Avison MJ, Gore JC. Anterior cingulate and cerebellar GABA and Glu correlations measured by (1)H J-difference spectroscopy. Magn. Reson. Imaging, 2010; 29(1): 19-24.
35. Goto N, Yoshimura R, Moriya J, Kakeda S, Hayashi K, Ueda N, Ikenouchi-Sugita A, Umene-Nakano W, Oonari N, Korogi Y, Nakamura J. Critical examination of a correlation between brain gamma-aminobutyric acid (GABA) concentrations and a personality trait of extroversion in healthy volunteers as measured by a 3 Tesla proton magnetic resonance spectroscopy study. Psychiatry Res. 2010; 182(1): 53-57.
36. Yoon JH, Maddock RJ, Rokem A, Silver MA, Minzenberg MJ, Ragland JD, Carter CS. GABA concentration is reduced in visual cortex in schizophrenia and correlates with orientation-specific surround suppression. J. Neurosci. 2010; 30(10): 3777-3781.
37. Kegeles LS, Mao X, Dyke J, Gonzales R, Soones TN, Shungu DC. Test-retest reliability of dorsolateral prefrontal cortical GABA measurement using an 8-channel phased-array head coil with the J-editing technique at 3T. Proceedings of the 14th Annual Meeting ISMRM, Seattle, WA, USA, 2006; 489.
38. Ham BJ, Sung Y, Kim N, Kim SJ, Kim JE, Kim DJ, Lee JY, Kim JH, Yoon SJ, Lyoo IK. Decreased GABA levels in anterior cingulate and basal ganglia in medicated subjects with panic disorder: a proton magnetic resonance spectroscopy (1H-MRS) study. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2007; 31(2): 403-411.
39. Garcia M, Huppertz HJ, Ziyeh S, Buechert M, Schumacher M, Mader I. Valproate-induced metabolic changes in patients with epilepsy: assessment with H-MRS. Epilepsia, 2009; 50(3): 486-492.
40. 1H spectroscopic imaging of human brain at 4. 1T using image segmentation. Magn. Reson. Med. 1996; 36(1): 21-29.
41. Jensen JE, Frederick Bde B, Renshaw PF. Grey and white matter GABA level differences in the human brain using two-dimensional, J-resolved spectroscopic imaging. NMR Biomed. 2005; 18(8): 570-576.
42. Choi IY, Lee SP, Merkle H, Shen J. In vivo detection of gray and white matter differences in GABA concentration in the human brain. Neuroimage, 2006; 33(1): 85-93.
43. Petroff OA, Spencer DD, Alger JR, Prichard JW. High-field proton magnetic resonance spectroscopy of human cerebrum obtained during surgery for epilepsy. Neurology, 1989; 39(9): 1197-1202.
44. Muthukumaraswamy SD, Edden RA, Jones DK, Swettenham JB, Singh KD. Resting GABA concentration predicts peak gamma frequency and fMRI amplitude in response to visual stimulation in humans. Proc. Natl. Acad. Sci. USA, 2009; 106(20): 8356-8361.
45. Donahue MJ, Near J, Blicher JU, Jezzard P. Baseline GABA concentration and fMRI response. Neuroimage, 2010; 53(2): 392-398.
46. Edden RA, Muthukumaraswamy SD, Freeman TC, Singh KD. Orientation discrimination performance is predicted by GABA concentration and gamma oscillation frequency in human primary visual cortex. J. Neurosci. 2009; 29(50): 15 721-15 726.
47. Dager SR, Friedman SD, Parow A, Demopulos C, Stoll AL, Lyoo IK, Dunner DL, Renshaw PF. Brain metabolic alterations in medication-free patients with bipolar disorder. Arch. Gen. Psychiatry, 2004; 61(5): 450-458.
48. Michaelis T, Merboldt KD, Bruhn H, Hanicke W, Frahm J. Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. Radiology, 1993; 187(1): 219-227.
49. Pan JW, Twieg DB, Hetherington HP. Quantitative spectroscopic imaging of the human brain. Magn. Reson. Med. 1998; 40(3): 363-369.